Encompass Health (NYSE:EHC) has received a consensus rating of “Buy” from the nine brokerages that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $67.33.
A number of brokerages have commented on EHC. Royal Bank of Canada boosted their target price on shares of Encompass Health to $69.00 and gave the stock an “outperform” rating in a report on Monday, April 30th. Robert W. Baird boosted their target price on shares of Encompass Health from $59.00 to $66.00 and gave the stock an “outperform” rating in a report on Monday, April 30th. SunTrust Banks reiterated a “buy” rating and issued a $70.00 target price on shares of Encompass Health in a report on Tuesday, April 17th. Craig Hallum boosted their target price on shares of Encompass Health from $63.00 to $71.00 and gave the stock a “buy” rating in a report on Monday, April 30th. Finally, ValuEngine upgraded shares of Encompass Health from a “buy” rating to a “strong-buy” rating in a report on Friday, April 27th.
Shares of EHC stock traded up $0.05 on Friday, hitting $63.79. The stock had a trading volume of 289,000 shares, compared to its average volume of 600,037. The company has a debt-to-equity ratio of 1.77, a current ratio of 1.24 and a quick ratio of 1.24. The company has a market capitalization of $6.30 billion, a P/E ratio of 23.09, a PEG ratio of 1.45 and a beta of 0.37. Encompass Health has a one year low of $42.21 and a one year high of $64.73.
Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, February 26th. The company reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1 billion. Encompass Health had a return on equity of 20.76% and a net margin of 6.76%. analysts anticipate that Encompass Health will post 3.39 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, July 16th. Shareholders of record on Monday, July 2nd will be issued a $0.25 dividend. The ex-dividend date of this dividend is Friday, June 29th. This represents a $1.00 dividend on an annualized basis and a yield of 1.57%. Encompass Health’s dividend payout ratio is presently 36.23%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.